Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 8/2009

01-08-2009 | Letter

Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico

Authors: A. Arredondo, E. de Icaza

Published in: Diabetologia | Issue 8/2009

Login to get access

Excerpt

To the Editor: Diabetes is a health problem that requires an integrated approach. The increasing incidence of diabetes has not been slowed by enhanced effort in providing treatments or by providing the economic resources necessary for these treatments. It is thought that the increase in the incidence of diabetes will continue. In Mexico, the prevalence of diabetes mellitus increased from 4.6% in 1993 to 22.8% in 2006 [1]. The impact of this disease is evident not only in mortality, but also in morbidity. This morbidity represents an enormous burden for individuals and their families, as well as for the health system and society in general [2]. …
Literature
1.
National Institute of Public Health (2009) Métodos de estimación de cambios epidemiológicos y demanda esperada de enfermedades crónico-degenerativas. Informe Técnico de Memoria Metodológica, Cuernavaca, México, pp 63–78
2.
Brown JB, Pedula KL, Bakst AW (1999) The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 159:1873–1880PubMedCrossRef
3.
International Diabetes Federation (1999) Direct cost to the health care sector. Diabetes health economics. International Diabetes Federation, Brussels, Belgium, pp 29–35
4.
Arredondo A, Barceló A (2007) The economic burden of out-of-pocket medical expenditures for patients seeking diabetes care in Mexico. Diabetologia 50:435–436CrossRef
5.
Barcelo A, Aedo C, Rajpathak S, Robles S (2003) The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ 81:19–27PubMed
Metadata
Title
Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico
Authors
A. Arredondo
E. de Icaza
Publication date
01-08-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1417-5

Other articles of this Issue 8/2009

Diabetologia 8/2009 Go to the issue

Article

Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes

Research Letter

Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births

Article

Phenotype–genotype interactions on renal function in type 2 diabetes: an analysis using structural equation modelling

Article

Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival

Article

Glucose metabolism and the risk of Alzheimer’s disease and dementia: a population-based 12 year follow-up study in 71-year-old men

Article

Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits